JP2010533132A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010533132A5 JP2010533132A5 JP2010515363A JP2010515363A JP2010533132A5 JP 2010533132 A5 JP2010533132 A5 JP 2010533132A5 JP 2010515363 A JP2010515363 A JP 2010515363A JP 2010515363 A JP2010515363 A JP 2010515363A JP 2010533132 A5 JP2010533132 A5 JP 2010533132A5
- Authority
- JP
- Japan
- Prior art keywords
- diseases
- cancer
- treatment
- carcinoma
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102007032739.2 | 2007-07-13 | ||
| DE102007032739A DE102007032739A1 (de) | 2007-07-13 | 2007-07-13 | Chinazolinamidderivate |
| PCT/EP2008/004846 WO2009010139A2 (de) | 2007-07-13 | 2008-06-16 | Chinazolinamidderivate |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010533132A JP2010533132A (ja) | 2010-10-21 |
| JP2010533132A5 true JP2010533132A5 (https=) | 2013-12-05 |
| JP5457343B2 JP5457343B2 (ja) | 2014-04-02 |
Family
ID=40121496
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010515363A Expired - Fee Related JP5457343B2 (ja) | 2007-07-13 | 2008-06-16 | キナゾリンアミド誘導体 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8501754B2 (https=) |
| EP (1) | EP2164833B1 (https=) |
| JP (1) | JP5457343B2 (https=) |
| KR (1) | KR20100044846A (https=) |
| CN (1) | CN101743229B (https=) |
| AR (1) | AR067506A1 (https=) |
| AU (1) | AU2008278032B2 (https=) |
| BR (1) | BRPI0814236A2 (https=) |
| CA (1) | CA2694475C (https=) |
| DE (1) | DE102007032739A1 (https=) |
| EA (1) | EA017585B1 (https=) |
| ES (1) | ES2538218T3 (https=) |
| IL (1) | IL203206A (https=) |
| WO (1) | WO2009010139A2 (https=) |
| ZA (1) | ZA201001058B (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102008061214A1 (de) * | 2008-12-09 | 2010-06-10 | Merck Patent Gmbh | Chinazolinamidderivate |
| AR077405A1 (es) | 2009-07-10 | 2011-08-24 | Sanofi Aventis | Derivados del indol inhibidores de hsp90, composiciones que los contienen y utilizacion de los mismos para el tratamiento del cancer |
| FR2949467B1 (fr) | 2009-09-03 | 2011-11-25 | Sanofi Aventis | Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation |
| AU2010315190A1 (en) * | 2009-11-05 | 2012-05-10 | Lexicon Pharmaceuticals, Inc. | Tryptophan hydroxylase inhibitors for the treatment of cancer |
| DE102009054302A1 (de) * | 2009-11-23 | 2011-05-26 | Merck Patent Gmbh | Chinazolinderivate |
| DE102010046837A1 (de) * | 2010-09-29 | 2012-03-29 | Merck Patent Gmbh | Phenylchinazolinderivate |
| PT2643313T (pt) | 2010-11-24 | 2016-10-11 | Merck Patent Gmbh | Quinazolina carboxamida azetidinas |
| GB2486631A (en) * | 2010-12-01 | 2012-06-27 | Univ Sheffield | Phenol/quinone boronic acids/esters and method of preparation thereof |
| TW201311149A (zh) * | 2011-06-24 | 2013-03-16 | Ishihara Sangyo Kaisha | 有害生物防治劑 |
| AU2014227992A1 (en) * | 2013-03-15 | 2015-11-05 | Rexahn Pharmaceuticals, Inc. | Tetrahydroisoquinolin-2-yl-(quinazolin-4-yl) methanone compounds as cancer cell growth inhibitors |
| US10138212B2 (en) | 2015-02-06 | 2018-11-27 | Merck Sharp & Dohme Corp. | Aminoquinazoline compounds as A2A antagonist |
| EP3317278B1 (en) * | 2015-07-01 | 2021-04-14 | Crinetics Pharmaceuticals, Inc. | Somatostatin modulators and uses thereof |
| KR20180086187A (ko) | 2015-10-05 | 2018-07-30 | 더 트러스티이스 오브 콜롬비아 유니버시티 인 더 시티 오브 뉴욕 | 자가포식 유동의 활성체 및 포스포리파제 d 및 타우를 포함하는 단백질 응집물의 클리어런스 및 단백질질환의 치료 |
| US11374044B2 (en) * | 2016-07-19 | 2022-06-28 | Nippon Kayaku Kabushiki Kaisha | Material for photoelectric conversion element for use in imaging element, and photoelectric conversion element including same |
| CN109111451B (zh) * | 2017-06-26 | 2020-08-11 | 广东东阳光药业有限公司 | 二氢嘧啶类化合物及其在药物中的应用 |
| CN107382976A (zh) * | 2017-07-04 | 2017-11-24 | 孙秀芹 | 一种治疗盆腔炎的化合物及制备方法和应用 |
| CN107488168A (zh) * | 2017-07-18 | 2017-12-19 | 黄绍菊 | 一种治疗盆腔炎的化合物及制备方法和应用 |
| US11028068B2 (en) | 2017-07-25 | 2021-06-08 | Crinetics Pharmaceuticals, Inc. | Somatostatin modulators and uses thereof |
| TWI853814B (zh) | 2018-05-31 | 2024-09-01 | 南韓商Ｃ＆Ｃ新藥研究所 | 雜環衍生物及其用途 |
| WO2022015938A1 (en) * | 2020-07-15 | 2022-01-20 | Ifm Due, Inc. | Compounds and compositions for treating conditions associated with sting activity |
| UY39892A (es) | 2021-08-10 | 2023-03-31 | Novartis Pharma Ag | Compuestos y composiciones para tratar afecciones asociadas con la actividad de STING |
| TW202400600A (zh) * | 2022-06-16 | 2024-01-01 | 美商昂勝醫療科技股份有限公司 | 喹唑啉衍生物、其組成物及方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5968921A (en) | 1997-10-24 | 1999-10-19 | Orgegon Health Sciences University | Compositions and methods for promoting nerve regeneration |
| AU3378599A (en) | 1998-04-03 | 1999-10-25 | University Of Pittsburgh | Benzoquinoid ansamycins for the treatment of cardiac arrest and stroke |
| JP2003523313A (ja) | 1999-03-12 | 2003-08-05 | アメリカ合衆国 | シャペロン蛋白質の阻害方法 |
| WO2001072779A1 (en) | 2000-03-24 | 2001-10-04 | Duke University | Characterization of grp94-ligand interactions and purification, screening, and therapeutic methods relating thereto |
| AU2001271567A1 (en) | 2000-06-29 | 2002-01-14 | Trustees Of Boston University | Use of geldanamycin and related compounds for prophylaxis or treatment of fibrogenic disorders |
| CA2416603A1 (en) | 2000-07-20 | 2003-01-31 | Merck & Co., Inc. | Inhibiting hepatitis c virus processing and replication |
| AU2001292548B2 (en) | 2000-07-28 | 2005-06-16 | Sloan-Kettering Institute For Cancer Research | Methods for treating cell proliferative disorders and viral infections |
| CN1300116C (zh) | 2001-04-16 | 2007-02-14 | 卫材株式会社 | 1h－吲唑化合物 |
| WO2003041643A2 (en) | 2001-11-09 | 2003-05-22 | Conforma Therapeutics Corporation | Hsp90-inhibiting zearalanol compounds and methods of producing and using same |
| AU2005266494B2 (en) | 2004-07-27 | 2009-09-10 | Novartis Ag | Inhibitors of Hsp90 |
| US20070054916A1 (en) * | 2004-10-01 | 2007-03-08 | Amgen Inc. | Aryl nitrogen-containing bicyclic compounds and methods of use |
| DE102005022977A1 (de) | 2005-05-19 | 2006-12-07 | Merck Patent Gmbh | Phenylchinazolinderivate |
-
2007
- 2007-07-13 DE DE102007032739A patent/DE102007032739A1/de not_active Withdrawn
-
2008
- 2008-06-16 WO PCT/EP2008/004846 patent/WO2009010139A2/de not_active Ceased
- 2008-06-16 EA EA201000098A patent/EA017585B1/ru not_active IP Right Cessation
- 2008-06-16 AU AU2008278032A patent/AU2008278032B2/en not_active Ceased
- 2008-06-16 CN CN2008800245618A patent/CN101743229B/zh not_active Expired - Fee Related
- 2008-06-16 BR BRPI0814236-0A2A patent/BRPI0814236A2/pt not_active IP Right Cessation
- 2008-06-16 JP JP2010515363A patent/JP5457343B2/ja not_active Expired - Fee Related
- 2008-06-16 US US12/668,864 patent/US8501754B2/en not_active Expired - Fee Related
- 2008-06-16 EP EP08773474.5A patent/EP2164833B1/de not_active Not-in-force
- 2008-06-16 KR KR1020107003221A patent/KR20100044846A/ko not_active Withdrawn
- 2008-06-16 ES ES08773474T patent/ES2538218T3/es active Active
- 2008-06-16 CA CA2694475A patent/CA2694475C/en not_active Expired - Fee Related
- 2008-07-11 AR ARP080102977A patent/AR067506A1/es unknown
-
2010
- 2010-01-07 IL IL203206A patent/IL203206A/en not_active IP Right Cessation
- 2010-02-12 ZA ZA2010/01058A patent/ZA201001058B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010533132A5 (https=) | ||
| JP2010516639A5 (https=) | ||
| Kunnumakkara et al. | Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins | |
| MX2024000208A (es) | Restos de administracion terapeutica novedosos y usos de estos. | |
| JP2019524883A5 (https=) | ||
| TW200640883A (en) | Compounds for the treatment of proliferative disorders | |
| CY1117440T1 (el) | Συτηκτα παραγωγα ιμιδαζολης ως αναστολεις toy ido | |
| AU2015231270B2 (en) | Antifungal compound process | |
| IL180979A (en) | Isoindulin compounds and their use | |
| EP3119754A1 (en) | Antifungal compound process | |
| WO2009066060A3 (en) | 4-substituted-6-isopropyl-benzene-1,3-diol compounds and their use | |
| JP2013521291A5 (https=) | ||
| JP2018527301A5 (ja) | アジリジン含有ｄｎａアルキル化剤 | |
| Huo et al. | 2-Arylindoles: concise syntheses and a privileged scaffold for fungicide discovery | |
| EA202090259A1 (ru) | Новые гетероариламидные производные как селективные ингибиторы гистондеацетилаз 1 и/или 2 (hdac1-2) | |
| TNSN07294A1 (en) | Treatment of metastasized tumors | |
| TW200745043A (en) | Substituted pyrazoline compounds, their preparation and use as medicaments | |
| MX2024002409A (es) | Terapias contra el cancer. | |
| Ozdemir et al. | Synthesis, anticonvulsant and antimicrobial activities of some new [1-(2-naphthyl)-2-(pyrazol-1-yl) ethanone] oxime ethers | |
| Movafagh et al. | Histone deacetylase inhibitors in cancer prevention and therapy | |
| WO2007009720A3 (en) | Prodrugs of pyrazoline compounds, their preparation and use as medicaments | |
| JP2017511340A5 (https=) | ||
| WO2007009721A3 (en) | Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments | |
| EA201270347A1 (ru) | Производные апогоссиполона в качестве противоопухолевых агентов | |
| WO2015081867A1 (zh) | 吉西他滨衍生物、含该衍生物的组合物及所述衍生物的制药用途 |